-
Something wrong with this record ?
HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae
P. Büttiker, GB. Stefano, S. Weissenberger, R. Ptacek, M. Anders, J. Raboch, RM. Kream
Status not-indexed Language English Country New Zealand
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2009
Free Medical Journals
from 2005
PubMed Central
from 2005
Europe PubMed Central
from 2005
ProQuest Central
from 2005-01-01
Open Access Digital Library
from 2005-01-01
Open Access Digital Library
from 2009-01-01
Taylor & Francis Open Access
from 2010-12-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
Psychology Database (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2005
PubMed
36221293
DOI
10.2147/ndt.s382308
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
- Review MeSH
Long COVID, in which disease-related symptoms persist for months after recovery, has led to a revival of the discussion of whether neuropsychiatric long-term symptoms after viral infections indeed result from virulent activity or are purely psychological phenomena. In this review, we demonstrate that, despite showing differences in structure and targeting, many viruses have highly similar neuropsychiatric effects on the host. Herein, we compare severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus 1 (HIV-1), Ebola virus disease (EVD), and herpes simplex virus 1 (HSV-1). We provide evidence that the mutual symptoms of acute and long-term anxiety, depression and post-traumatic stress among these viral infections are likely to result from primary viral activity, thus suggesting that these viruses share neuroinvasive strategies in common. Moreover, it appears that secondary induced environmental stress can lead to the emergence of psychopathologies and increased susceptibility to viral (re)infection in infected individuals. We hypothesize that a positive feedback loop of virus-environment-reinforced systemic responses exists. It is surmised that this cycle of primary virulent activity and secondary stress-induced reactivation, may be detrimental to infected individuals by maintaining and reinforcing the host's immunocompromised state of chronic inflammation, immunological strain, and maladaptive central-nervous-system activity. We propose that this state can lead to perturbed cognitive processing and promote aversive learning, which may manifest as acute, long-term neuropsychiatric illness.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22031610
- 003
- CZ-PrNML
- 005
- 20230127131234.0
- 007
- ta
- 008
- 230119s2022 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/NDT.S382308 $2 doi
- 035 __
- $a (PubMed)36221293
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Büttiker, Pascal $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000193664225
- 245 10
- $a HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae / $c P. Büttiker, GB. Stefano, S. Weissenberger, R. Ptacek, M. Anders, J. Raboch, RM. Kream
- 520 9_
- $a Long COVID, in which disease-related symptoms persist for months after recovery, has led to a revival of the discussion of whether neuropsychiatric long-term symptoms after viral infections indeed result from virulent activity or are purely psychological phenomena. In this review, we demonstrate that, despite showing differences in structure and targeting, many viruses have highly similar neuropsychiatric effects on the host. Herein, we compare severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus 1 (HIV-1), Ebola virus disease (EVD), and herpes simplex virus 1 (HSV-1). We provide evidence that the mutual symptoms of acute and long-term anxiety, depression and post-traumatic stress among these viral infections are likely to result from primary viral activity, thus suggesting that these viruses share neuroinvasive strategies in common. Moreover, it appears that secondary induced environmental stress can lead to the emergence of psychopathologies and increased susceptibility to viral (re)infection in infected individuals. We hypothesize that a positive feedback loop of virus-environment-reinforced systemic responses exists. It is surmised that this cycle of primary virulent activity and secondary stress-induced reactivation, may be detrimental to infected individuals by maintaining and reinforcing the host's immunocompromised state of chronic inflammation, immunological strain, and maladaptive central-nervous-system activity. We propose that this state can lead to perturbed cognitive processing and promote aversive learning, which may manifest as acute, long-term neuropsychiatric illness.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Stefano, George B $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Weissenberger, Simon $u Department of Psychology, University of New York in Prague, Prague, Czech Republic $1 https://orcid.org/0000000263949884
- 700 1_
- $a Ptacek, Radek $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000210762506
- 700 1_
- $a Anders, Martin $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000330393266
- 700 1_
- $a Raboch, Jiri $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000276089094
- 700 1_
- $a Kream, Richard M $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 773 0_
- $w MED00183034 $t Neuropsychiatric disease and treatment $x 1176-6328 $g Roč. 18, č. - (2022), s. 2229-2237
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36221293 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230119 $b ABA008
- 991 __
- $a 20230127131226 $b ABA008
- 999 __
- $a ok $b bmc $g 1889570 $s 1182943
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2022 $b 18 $c - $d 2229-2237 $e 20221005 $i 1176-6328 $m Neuropsychiatric disease and treatment $n Neuropsychiatr Dis Treat $x MED00183034
- LZP __
- $a Pubmed-20230119